Biomarkers predictive of a response to extended endocrine therapy in breast cancer: a systematic review and meta-analysis Kirsten M. WoolpertThomas P. AhernDeirdre P. Cronin-Fenton Review Open access 25 October 2023 Pages: 407 - 417
Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer Dan MoldoveanuTanya L. HoskinJudy C. Boughey Review 25 October 2023 Pages: 419 - 428
Association of physical weight statuses defined by body mass index (BMI) with molecular subtypes of premenopausal breast cancer: a systematic review and meta-analysis Xuchu LiJinping LiFang Chen Review 26 October 2023 Pages: 429 - 447
Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons Sohee ParkChanghoon ChoiNalee Kim Preclinical study 30 October 2023 Pages: 449 - 461
Outcomes of male patients with HR+/HER2– advanced breast cancer receiving palbociclib in the real-world POLARIS study Joanne L. BlumCaroline DiCristoDebu Tripathy Clinical trial Open access 30 October 2023 Pages: 463 - 475
Optimizing surgical strategy in locally advanced breast cancer: a comparative analysis between preoperative MRI and postoperative pathology after neoadjuvant chemotherapy K. K. RajanC. BoersmaE. M. Noorda Clinical trial 04 November 2023 Pages: 477 - 486
Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancer M. GaudioF. JacobsA. Zambelli Clinical trial 04 November 2023 Pages: 487 - 495
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study Diogo Martins-BrancoMarie KassapianEvandro de Azambuja Clinical Trial 08 November 2023 Pages: 497 - 509
Positive predictive value of axillary lymph node cortical thickness and nodal, clinical, and tumor characteristics in newly diagnosed breast cancer patients Anne-Sophie T. LoonisAllyson L. ChesebroCatherine S. Giess Clinical trial 10 November 2023 Pages: 511 - 521
European quality indicators developed by the European Commission Initiative on Breast Cancer: a first nationwide assessment for the Dutch setting Kay SchreuderTim J. BultSabine Siesling Epidemiology 26 October 2023 Pages: 523 - 531
Risk of contralateral breast cancer among Asian/Pacific Islander women in the United States Hsiao-Ching HuangJenny S. GuadamuzGregory S. Calip Epidemiology 28 October 2023 Pages: 533 - 542
Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients Yuan-Yuan ZhaoHui-Juan GeShuang Hao Epidemiology 28 October 2023 Pages: 543 - 551
Racial/ethnic disparities in the association between patient care experiences and receipt of initial surgical breast cancer care: findings from SEER-CAHPS Mariana ArevaloTrevor A. PickeringAlbert J. Farias Epidemiology 31 October 2023 Pages: 553 - 564
Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system Elizabeth D. KantorKelli O’ConnellLawrence H Kushi Epidemiology 04 November 2023 Pages: 565 - 574
Individual and area level factors associated with the breast cancer diagnostic-treatment interval in Queensland, Australia James D. RetellJessica K. CameronPeter D. Baade Epidemiology Open access 06 November 2023 Pages: 575 - 586
A new methodology to predict the oncotype scores based on clinico-pathological data with similar tumor profiles Zeina Al MasryRomain PicChrisine Devalland Epidemiology 06 November 2023 Pages: 587 - 598
Screening mammographic performance by race and age in the National Mammography Database: 29,479,665 screening mammograms from 13,181,241 women Cindy S. LeeLenka GoldmanLinda Moy Original Laboratory Investigation 28 October 2023 Pages: 599 - 612
Palbociclib sensitizes ER-positive breast cancer cells to fulvestrant by promoting the ubiquitin-mediated degradation of ER-α via SNHG17/Hippo-YAP axis Lei LeiYuan HuangYabing Zheng Original Laboratory Investigation Open access 04 November 2023 Pages: 613 - 625
Interleukin-6 and C-Reactive protein in metastatic breast cancer patients treated with eribulin Kadri Altundag Letter to the Editor 25 October 2023 Pages: 627 - 627
Percutaneous and intravenous contrast material injection in contrast-enhanced ultrasound for sentinel lymph node evaluation in patients with breast cancer: importance of discussing difference in purposes Naoko Mori Letter to the Editor 04 November 2023 Pages: 629 - 630